DNA Histogram oncodx.com
spacer
About Us
Cancers
Research
Cancer Links
Request A Test
Contact Us
spacer
Looking Closer at Cancers
Bladder Cancer
Breast Cancer
Central Nervous System Cancer
Cervical Cancer
Colorectal Cancer
Endomentrial Cancer
Esophageal Carcinoma
Gastric Cancer
Gestatinal Trophblastic Disease
Lung Cancer
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Sarcomas
Testis Cancer
spacer
UT Southwestern Medical Center, Veripath Laboratories

 

 spacer
About Veripath Oncodiagnostics
Dr. Raheela Ashfaq spacer


Mission Statement
"Fighting for your Life"

The turn of the last century witnessed a veritable explosion of information in the field of cancer research, which has greatly enhanced our understanding of why normal cells become malignant. A critical paradigm shift has been the realization that every cancer, like the individual it arises in, is unique.

In other words, we are moving from an era of generalizations into specific "profiling" of individual cancers, and tailoring therapy appropriately. The successful application of expression arrays and proteomics to the study of cancers has remarkably expanded the armamentarium of abnormal markers (i.e., cellular proteins) that distinguish neoplastic cells from their benign counterparts. It is becoming increasingly evident that aberrant expression of proteins in cancer cells is not merely an epiphenomenona of malignancy, but plays an active part in the genesis and progression of tumors. Incorporation of expression data into risk stratification of cancers has repeatedly proved to be a powerful tool, and most recommended tumor prognostic panels now include some form of protein expression data as a routine component.

The mission of the Veripath OncoDiagnostics is to provide the clinician with a "protein expression profile" of every cancer that will result in the most appropriate therapy for the individual patient. To this end, the laboratory continues to keep pace with the field of cancer proteomics, expanding our compendium of available markers for tumor profiling on an ongoing basis. Through continuious discussion with our surgeons and oncologists we formulate rational expression panels for individual patients or cancers by merging state of the art technology with cost effective use of resources. We strongly believe that the availability of the cancer-specific information will be an invaluable resource for diagnosticians, medical and surgical oncologists alike.

Faculty Bio Link

Veripath OncoDiagnostics Laboratory is staffed by Physicians at University of Texas Southwestern, Medical Center, Dallas

  
Markers Available

spacer


Micrometastasis Analysis
Androgen Receptor
APC
B-Catenin
BCL-2
Bax
DNA Ploidy
CD9
CD34
CD44
CD44v6
CD117
c-Myc
COX-2
CTC New Test New
Cyclin DI
Cyclin E
E-caderin
EGFR
EGFR PharmDx
ER/PR
FHIT
KAI-1
K-RAS
GST
hMLH-1
hMSH-2
Her-2/neu
Her 2/neu by FISH
Metallothionein
MIB-1
1p/19q by FISH
P16
P21
P27
P53
P57
p-Glyoprotein
p-Her2/neu
PTEN
SMAD-4
Thymidylate Synthase
uPA/PAI-1
VEGF
UroVysion by FISH

 

| home | about us | cancers | research | cancer links | request a test | contact us |


Veripath OncoDiagnostics
2110 Research Row, Dallas, TX 75235